1. Headache in the development of neurosciences

   • Elio Agostoni

   EDITORIAL 12 November 2020 Pages: 349 - 350

2. Migraine neuroscience: from experimental models to target therapy

   • Rosaria Greco
   • Chiara Demartini
   • Cristina Tassorelli

   KEY LECTURE 25 October 2020 Pages: 351 - 361

3. Role of neuroimaging in headaches’ clinical management

   • Cinzia Finocchi
   • Monica Bandettini

   NEUROIMAGING IN HEADACHE RESEARCH AND DIAGNOSTICS 24 August 2020 Pages: 363 - 365

4. Cluster headache and TACs: state of the art

   • Luca Giani
   • Alberto Proietti Cecchini
   • Massimo Leone

   MIGRAINE AND PRIMARY HEADACHES 26 August 2020 Pages: 367 - 375

   

5. Other primary headaches. Cough headache, nummular headache and primary exercise headache: a secondary point of view

   • Bruno Colombo
   • Massimo Filippi

   MIGRAINE AND PRIMARY HEADACHES 08 September 2020 Pages: 377 - 379

   

6. Moving closer to the ideal migraine acute treatment

   • Sabina Cevoli
   • Umberto Pensato
   • Valentina Favoni

   THERAPEUTICAL SCENARIOS IN HEADACHES 03 September 2020 Pages: 381 - 382

7. Migraine and prophylaxis

   • Licia Grazzi

   THERAPEUTICAL SCENARIOS IN HEADACHES 18 September 2020 Pages: 383 - 384

8. Primaries non-migraine headaches treatment: a review

   • Fabio Frediani
   • Gennaro Bussone

   THERAPEUTICAL SCENARIOS IN HEADACHES 06 October 2020 Pages: 385 - 394

9. Headache in cervicocerebral artery dissection

   • Simone Vidale

   HEADACHES AND CEREBROVASCULAR DISEASE 27 August 2020 Pages: 395 - 399

   

10. Headache in cerebral venous thrombosis

    • Angelo Aliprandi
    • Paolo Borelli
    • Andrea Salmaggi

    HEADACHES AND CEREBROVASCULAR DISEASE 06 October 2020 Pages: 401 - 406

    

11. Headache following endovascular procedures

    • Matteo Paolucci
    • Marco Longoni
    • Elio Clemente Agostoni

    HEADACHES AND CEREBROVASCULAR DISEASE 24 September 2020 Pages: 407 - 408

12. Headache in neurological emergency

    • Marco Longoni
    • Elio Clemente Agostoni

    KEY LECTURE 01 October 2020 Pages: 409 - 416

13. Headache in idiopathic intracranial hypertension. A CGRP-dependent head pain?

    • Roberto De Simone
    • Mattia Sansone
    • Vincenzo Bonavita

    HEADACHES IN CSF DYNAMICS DISORDERS 27 August 2020 Pages: 417 - 421

14. Headache in spontaneous intracranial hypotension: an overview with indications for differential diagnosis in the clinical practice

    • Domenico D’Amico
    • Susanna Usai
    • Massimo Leone

    HEADACHES IN CSF DYNAMICS DISORDERS 09 October 2020 Pages: 423 - 427

15. Gender-related differences in migraine

    • Gianni Allais
    • Giulia Chiarle
    • Chiara Benedetto

    KEY LECTURE Open access 26 August 2020 Pages: 429 - 436

16. Sleep and migraine

    • Paola Proserpio
    • Elio Clemente Agostoni

    THE SPECTRUM OF MIGRAINE COMORBIDITIES 03 September 2020 Pages: 437 - 438

17. Migraine and rare neurological disorders

    • Emma Scelzo
    • Markus Kramer
    • Anna Bersano

    THE SPECTRUM OF MIGRAINE COMORBIDITIES 03 September 2020 Pages: 439 - 446

18. Stress in paediatric migraine: a trigger factor?

    • Bruno Colombo
    • Ilaria Cetta
    • Massimo Filippi

    BRIEF COMMUNICATION 26 August 2020 Pages: 447 - 449

    

19. Appropriateness of magnetic resonance angiography in the evaluation of migraine patients

    • Marco Russo
    • Gianni De Berti
    • Arens Taga

    BRIEF COMMUNICATION 26 August 2020 Pages: 451 - 452

20. Osmophobia in migraine: multifactorial investigation and population-based survey

    • Carlo Lovati
    • Denis Lombardo
    • Leonardo Pantoni

    BRIEF COMMUNICATION 15 August 2020 Pages: 453 - 454

21. Sleep, sleep apneas, and headache in general population

    • Stefania Peruzzo
    • Carlo Lovati
    • Leonardo Pantoni

    BRIEF COMMUNICATION 27 August 2020 Pages: 455 - 456

22. Erenumab efficacy in highly resistant chronic migraine: a real-life study

    • Umberto Pensato
    • Valentina Favoni
    • Sabina Cevoli

    BRIEF COMMUNICATION 27 August 2020 Pages: 457 - 459

23. Effectiveness of mindfulness by smartphone, for patients with chronic migraine and medication overuse during the Covid-19 emergency

    • Licia Grazzi
    • Paul Rizzoli
    • Frank Andrasik

    BRIEF COMMUNICATION 13 August 2020 Pages: 461 - 462

24. A longitudinal clinical and MRI evaluation of the treatment with erenumab

    • Alberto Coccia
    • Caterina Lapucci
    • Cinzia Finocchi

    BRIEF COMMUNICATION Open access 26 August 2020 Pages: 463 - 464

25. Efficacy and safety of erenumab in the real-life setting of S. Antonio Abate Hospital’s Headache Center (Gallarate)

    • Elisabetta Dalla Valle
    • Manlio Di Falco
    • Isidoro La Spina

    BRIEF COMMUNICATION 09 November 2020 Pages: 465 - 465

26. Migraineurs’ psychological traits do not influence response to erenumab

    • Claudia Altamura
    • Carmelinda Costa
    • Fabrizio Vernieri

    BRIEF COMMUNICATION 27 August 2020 Pages: 467 - 468

27. Mindfulness as an add-on treatment for patients with chronic migraine and medication overuse: a preliminary analysis

    • Emanuela Sansone
    • Licia Grazzi
    • Domenico D’Amico

    BRIEF COMMUNICATION 26 August 2020 Pages: 469 - 471

28. Sleep, headache and sleep breathing disturbances: a polisomnographic study

    • Carlo Lovati
    • Stefania Peruzzo
    • Leonardo Pantoni

    BRIEF COMMUNICATION 26 August 2020 Pages: 473 - 474

29. Clinical and radiological prognostic factors in spontaneous intracranial hypotension: a case series

    • Umberto Pensato
    • Cristina Russo
    • Giulia Pierangeli

    BRIEF COMMUNICATION 26 August 2020 Pages: 475 - 477

    

30. Efficacy of erenumab 70 mg in chronic migraine: Vicenza experience

    • Caterina Disco
    • Giuseppe Billo
    • Francesco Perini

    BRIEF COMMUNICATION 26 August 2020 Pages: 479 - 480

31. Headache relevance in outpatient activity during Covid-19 pandemic

    • Francesca Gatti
    • Letizia Manneschi

    Brief Communication 27 August 2020 Pages: 481 - 482

32. Erenumab in 159 high frequency and chronic migraine patients: real-life results from the Bologna Headache Center

    • Eleonora Matteo
    • Valentina Favoni
    • Sabina Cevoli

    BRIEF COMMUNICATION 29 August 2020 Pages: 483 - 484

33. Anti-CGRP monoclonal antibodies in cluster headache: what can we learn from recent clinical trials

    • Luca Giani
    • Alberto Proietti Cecchini
    • Massimo Leone

    BRIEF COMMUNICATION 26 August 2020 Pages: 485 - 486

34. Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)

    • Fabrizio Vernieri
    • Claudia Altamura
    • Piero Barbanti

    BRIEF COMMUNICATION 26 August 2020 Pages: 487 - 488

    

35. Erenumab efficacy in chronic migraine and medication overuse: a real-life multicentric Italian observational study

    • Francesca Schiano di Cola
    • Renata Rao
    • Alessandro Padovani

    BRIEF COMMUNICATION 27 August 2020 Pages: 489 - 490

    

36. Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis

    • Angelo Pascarella
    • Antonio De Martino
    • Francesco Bono

    BRIEF COMMUNICATION 26 August 2020 Pages: 491 - 492

37. Headache burden in a HIV population of sub-Saharan Africa: scope and implications from a pilot study

    • Luca Giani
    • Monica Mwazangati
    • Massimo Leone

    BRIEF COMMUNICATION 26 August 2020 Pages: 493 - 494

38. Poor sleep quality in patients affected by migraine: a population study

    • Giovanna Viticchi
    • Claudia Altamura
    • Marco Bartolini

    BRIEF COMMUNICATION 27 August 2020 Pages: 495 - 496

    

39. Cluster headache and risk of chronic transformation

    • Luca Giani
    • Alberto Proietti Cecchini
    • Massimo Leone

    BRIEF COMMUNICATION 26 August 2020 Pages: 497 - 498

40. Drug withdrawal along with bridge therapy with methylprednisolone and/or diazepam for treatment of medication overuse headache: a preliminary report from the WASH-OUT study

    • Fabrizio Vernieri
    • Patrizio Pasqualetti
    • Claudia Altamura

    BRIEF COMMUNICATION 27 August 2020 Pages: 499 - 501

    

41. Headache in a group of SARS-COVID-19 patients: an observational prospectical study

    • Alfonso Coppola
    • Maria Clara Tonini
    • Garbagnate Covid Group

    BRIEF COMMUNICATION 11 September 2020 Pages: 503 - 504

42. One year experience with erenumab: real-life data in 30 consecutive patients

    • Angelo Ranieri
    • Gennaro Alfieri
    • Valentino Manzo

    BRIEF COMMUNICATION 26 August 2020 Pages: 505 - 506

43. Exploring new strategy in erenumab therapy for migraine patients

    • Fabio Frediani
    • Giacomo D’Arrigo
    • Paola Di Fiore

    BRIEF COMMUNICATION 28 August 2020 Pages: 507 - 508

    

44. Effectiveness of erenumab in chronic migraine patients with associated medication overuse headache: a prospective observational study

    • Marcella Curone
    • Vincenzo Tullo
    • Gennaro Bussone

    BRIEF COMMUNICATION 08 September 2020 Pages: 509 - 510